Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Supreme Court shreds nationwide $6 billion opioid settlement plan in ruling against Sackler family

The Supreme Court said the Sackler family cannot use a Chapter 11 reorganization plan to protect themselves from civil liability

The Independent UK

US supreme court blocks Purdue Pharma’s bankruptcy settlement that would shield Sacklers from lawsuits

Controversial deal would have protected billionaire family owners from further liability over US opioid epidemic

The Guardian - US

Walgreens to take a hard look at underperforming stores, could shutter hundreds more

Walgreens is finalizing a plan to fix its business that could result in the closure of hundreds of additional stores in the next three years

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

The Supreme Court rejects a nationwide opioid settlement with OxyContin maker Purdue Pharma

The Supreme Court has rejected a nationwide settlement with OxyContin maker Purdue Pharma that would've shielded Sackler family members who own the company from civil lawsuits over the toll of opioids but also would've provided billions of dollars to combat the epidemic

The Independent UK

Stocks To Watch: Biotech Leader TG Therapeutics Clears Resistance Area

Among the best stocks to watch, biotech leader TG Therapeutics is clearing a key resistance area on the stock market today.

Investors Business Daily

How IBD Stock Of The Day Blueprint Medicines 'Knocked It Out Of The Park'

Blueprint Medicines is Tuesday's IBD Stock Of The Day. Shares are breaking a trendline, giving investors an early entry within a flat base.

Investors Business Daily

Biotech Stock Explodes On Drug Trial News As Sales Keep Doubling

This biotech stock nears a buy point after an explosive move following positive drug trial news. Sales have grown by triple-digits for seven quarters.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Organ-on-chip market for drug testing expected to see tenfold growth to $1.3 billion by 2032

Pharmaceutical and cosmetic companies are the number one consumers of this tech, but other industries are taking notice.

Tom’s Hardware

Ozempic maker Novo Nordisk invests $4bn to meet US ‘skinny jab’ demand

Pharma group plans plant in North Carolina to produce diabetes drug and weight-loss product Wegovy

The Guardian - UK

Pharmacists say they were not consulted on ‘rushed’ Labor-Greens vape deal

Federal health minister counters that Pharmacy Guild did not make submission to regulation inquiry and selling vapes still a decision for individual stores

The Guardian - AU

The Future of Weight-Loss Drugs for Investors

Weight-loss drugs’ impact could reach far beyond their target user, potentially creating headwinds for shares of snack makers and packaged-food firms, as well as medical device makers that specialize in knee replacements, insulin pumps and sleep apnea machines.

Kiplinger

AMD's Strix Halo being tested with 128GB RAM — shipping records reveal more about extreme 120W APU

AMD's upcoming Strix Halo APU, never confirmed but seen in shipping records and other leaks, has been spotted again in trade data: now with 128GB of RAM and 120W TDP.

Tom’s Hardware

Why A Broken Wing Butterfly Might Make Money In Gilead Sciences Stock

Support for Gilead shares sits near 57.

Investors Business Daily

Sarepta Catapults 30% After Hitting A 'Grand Slam' Approval In Muscular Dystrophy

Sarepta stock rocketed Friday after hitting a "grand slam" approval that expands the market for its Duchenne muscular dystrophy gene therapy more than tenfold, according to one estimate.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times

New $1.2 Bn Plan To Boost African Vaccine Production Launched

A new $1.2 billion programme to massively boost vaccine production in Africa was launched on Thursday, aiming to give the continent more sovereignty to fight numerous diseases including a cholera resurgence.

The Guardian - UK

Spanish police arrest 10 after discovery of ‘highly sophisticated’ meth lab

Mobile facility found near Barcelona was capable of producing 10kg of drug a day, say police, who seized 70kg

International Business Times

Over $1 Billion Pledged To Create 'African Vaccine Market'

World leaders, health groups and pharmaceutical firms announced $1.2 billion in funding at a summit Thursday to produce vaccines in Africa, which is facing numerous health crises including rising cholera outbreaks.

Tom’s Hardware

AMD working with law enforcement after reports of massive data breach — hack may have uncovered future product details

Known cybercriminal Intelbroker claims to have breached AMD and got plenty of sensitive information that is now available for sale.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Why 93% Of Aerovate Therapeutics' Value Just Went Up In Smoke

Aerovate Therapeutics said Monday its experimental blood pressure medicine failed in Phase 2 testing, and the biotech stock plummeted 93%.

StockNews.com

3 Small-Cap Healthcare Stocks Wall Street Loves

The healthcare industry is expected to witness robust growth driven by increased demand for medicines. Therefore, small-cap Wall Street healthcare favorites Amphastar Pharmaceuticals (AMPH), Catalyst Pharmaceuticals (CPRX), and Equillium (EQ) might be ideal additions to your portfolio. Keep reading….

The Independent UK

Abortion pill access is unchanged after the Supreme Court's decision. Here's what you need to know

A unanimous Supreme Court ruling means the abortion pill mifepristone remains available, including via mail delivery

Top News

Supreme Court Upholds FDA Approval Process For Abortion Drug

Supreme Court ruling on FDA's mifepristone regulations post-Dobbs v. Jackson Women’s Health Organization overturning Roe v. Wade, emphasizing engagement in...

The Independent UK

Supreme Court throws out challenge to key abortion pill mifepristone

Supreme Court rejected conservative group’s attempt to restrict access to abortion pill medication but left the door open for further lawsuits

Investors Business Daily

Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test

Sarepta stock jumped Thursday after Pfizer's rival gene therapy for Duchenne muscular dystrophy failed in final-phase testing.

Investors Business Daily

Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks

There hasn't been a new COPD treatment in years. But Regeneron stock analysts are closely watching a pair of key FDA decisions.

1 … 17 18 19 20

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.